Soluble interleukin-2 receptor: elevated levels in serum and synovial fluid of patients with rheumatoid arthritis.
Soluble interleukin-2 receptor (sIL-2R) levels were quantitated in the serum and synovial fluid (SF) of patients with rheumatoid arthritis (RA) and degenerative joint disease (DJD). A sandwich immunoassay, employing two monoclonal antibodies against distinct epitopes on the IL-2R, was utilized for measurement. We found a striking elevation of sIL-2R in RA SF as compared with DJD SF (RA, 1319 +/- 135; DJD, 416 +/- 59; p less than 0.001). RA serum sIL-2R levels were also significantly elevated over DJD levels. There was no interaction between rheumatoid factor (RF) and sIL-2R. RA patients with elevated sIL-2R levels had significantly longer disease duration, higher c-reactive protein (CRP) levels in serum and SF, and higher RF levels in serum and SF. The groups were similar in regard to other laboratory variables. The presence of elevated levels of sIL-2R in RA serum and SF confirms the presence of a heightened immune reactivity and in vivo activation of lymphocytes in RA.
Carpenter
A B
AB
Department of Pathology, University of Pittsburgh School of Medicine, Pennsylvania.
Eisenbeis
C H
CH
Carrabis
S
S
Brown
M C
MC
Ip
S H
SH
D001172:Arthritis, Rheumatoid / Q000097:blood / Q000378:metabolism*; D006801:Humans; D007118:Immunoassay / Q000379:methods; D007592:Joint Diseases / Q000097:blood / Q000378:metabolism; D008875:Middle Aged; D015375:Receptors, Interleukin-2 / Q000097:blood / Q000378:metabolism*; D012217:Rheumatoid Factor / Q000097:blood / Q000378:metabolism; D012995:Solubility; D013582:Synovial Fluid / Q000378:metabolism*
D015375:Receptors, Interleukin-2; D012217:Rheumatoid Factor